Home - Products - Others - Platelet aggregation - ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate

ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate

CAS No. 2738381-94-5

ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate( —— )

Catalog No. M28952 CAS No. 2738381-94-5

ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate is a platelet aggregation inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 221 In Stock
5MG 216 In Stock
10MG 322 In Stock
25MG 544 In Stock
50MG 719 In Stock
100MG 958 In Stock
200MG 1293 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate
  • Note
    Research use only, not for human use.
  • Brief Description
    ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate is a platelet aggregation inhibitor.
  • Description
    ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate is a platelet aggregation inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Platelet aggregation
  • Recptor
    Cysteine protease|CYP3A4|CCR4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2738381-94-5
  • Formula Weight
    386.4
  • Molecular Formula
    C22H18N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCOC(c1c(C)nc(-c2cc(C#N)ccc2)n1OCc(cc1)ccc1C#N)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhou Y, et al. Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Res. 2015 Apr;116:76-84.
molnova catalog
related products
  • Etizolam

    Etizolam is a selective platelet-activating factor (PAF) antagonist.

  • Rocepafant

    Rocepafant (LAU8080) is a platelet-activating factor (PAF) antagonist that attenuates hypoxic-ischemic brain damage in neonatal rats.

  • Pseudojervine

    Pseudojervine is derived from Veratrum nigrum L. Pseudojervine exhibits feeble inhibition activity against platelet aggregation.